Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-02

Clinical Trial Update: Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients

View source ↗

Summary

This completed NIH-sponsored trial explored using bromodeoxyuridine to study white blood cell replication and survival in HIV-infected patients (HIV infection a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromodeoxyuridine (5-bromodeoxyuridine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection, Acquired Immunodeficiency Syndrome | Status: COMPLETED